Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lidia Cerquetti"'
Autor:
Lidia Cerquetti, Barbara Bucci, Salvatore Raffa, Donatella Amendola, Roberta Maggio, Pina Lardo, Elisa Petrangeli, Maria Rosaria Torrisi, Vincenzo Toscano, Giuseppe Pugliese, Antonio Stigliano
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
The lack of an effective medical treatment for adrenocortical carcinoma (ACC) has prompted the search for better treatment protocols for ACC neoplasms. Sorafenib, a tyrosine kinase inhibitor has exhibited effectiveness in the treatment of different h
Externí odkaz:
https://doaj.org/article/46f8e3e0c533403d98c7547dcf7359a5
Autor:
Camilla Sampaoli, Lidia Cerquetti, Randa El Gawhary, Barbara Bucci, Donatella Amendola, Rodolfo Marchese, Silvia Misiti, Giuseppe Novelli, Vincenzo Toscano, Antonio Stigliano
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45129 (2012)
Adrenocortical carcinoma (ACC) is a very rare endocrine tumour, with variable prognosis, depending on tumour stage and time of diagnosis. However, it is generally fatal, with an overall survival of 5 years from detection. Radiotherapy usefulness for
Externí odkaz:
https://doaj.org/article/8904fdaa23954993a268045051389ca6
Autor:
Roberta Maggio, Vincenzo Toscano, Salvatore Raffa, Pina Lardo, Elisa Petrangeli, Antonio Stigliano, Chiara Simonini, Lidia Cerquetti, Giuseppe Pugliese, Barbara Bucci
Publikováno v:
Endocrine Abstracts.
Autor:
Roberta Maggio, Pina Lardo, Barbara Bucci, Antonio Stigliano, Donatella Amendola, Salvatore Raffa, Lidia Cerquetti, Elisa Petrangeli, Giuseppe Pugliese, Vincenzo Toscano, Maria Rosaria Torrisi
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology
Frontiers in Endocrinology
The lack of an effective medical treatment for adrenocortical carcinoma (ACC) has prompted the search for better treatment protocols for ACC neoplasms. Sorafenib, a tyrosine kinase inhibitor has exhibited effectiveness in the treatment of different h
Publikováno v:
Oncology Reports. 37:1301-1311
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with an incidence ranging from 0.7 to 2.0 cases/million people per year. Hypercortisolism represents the most common clinical presentation in many patients although, less frequently, some
Autor:
Barbara Bucci, Lidia Cerquetti, Giulia Carpinelli, Antonella Proietti, Vincenzo Toscano, Elisa Petrangeli, Guido Rindi, Pina Lardo, Antonio Stigliano, Raffaele Saporito
Publikováno v:
Cancers
Volume 11
Issue 11
Cancers, Vol 11, Iss 11, p 1768 (2019)
Volume 11
Issue 11
Cancers, Vol 11, Iss 11, p 1768 (2019)
Mitotane (MTT) is an adrenolytic drug used in adjuvant and advanced treatments of adrenocortical carcinoma (ACC). Ionizing radiation (IR) is also used in adrenal cancer treatment, even though its biological action remains unknown. To provide a reliab
Autor:
Beatrice Rubin, Elisa Taschin, Franco Grimaldi, Carla Scaroni, Daniela Regazzo, F. Pecori Giraldi, Marco Boscaro, Nora Albiger, Alfonso Massimiliano Ferrara, Antonio Stigliano, Silvia Rizzati, Giorgio Arnaldi, E. De Menis, Maurizio Iacobone, Filippo Ceccato, Gianluca Occhi, Lidia Cerquetti
Publikováno v:
Endocrine. 55:959-968
ARMC5 mutations have recently been identified as a common genetic cause of primary bilateral macronodular adrenal hyperplasia (PBMAH). We aimed to assess the prevalence of ARMC5 germline mutations and correlate genotype with phenotype in a large coho
Autor:
Paolo Marchetti, Maria Rosaria Nardone, Gabriela Capriotti, Francesca Schiavi, Iolanda Matarazzo, Pina Lardo, Antonio Stigliano, Elisa Petrangeli, Anna Maria Aschelter, Lidia Cerquetti, Vincenzo Toscano
Publikováno v:
Medicine (Baltimore. Online) 97 (2018): e10904. doi:10.1097/MD.0000000000010904
info:cnr-pdr/source/autori:Stigliano A.; Lardo P.; Cerquetti L.; Aschelter A.M.; Matarazzo I.; Capriotti G.; Schiavi F.; Marchetti P.; Nardone M.R.; Petrangeli E.; Toscano V./titolo:Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report/doi:10.1097%2FMD.0000000000010904/rivista:Medicine (Baltimore. Online)/anno:2018/pagina_da:e10904/pagina_a:/intervallo_pagine:e10904/volume:97
Medicine
info:cnr-pdr/source/autori:Stigliano A.; Lardo P.; Cerquetti L.; Aschelter A.M.; Matarazzo I.; Capriotti G.; Schiavi F.; Marchetti P.; Nardone M.R.; Petrangeli E.; Toscano V./titolo:Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report/doi:10.1097%2FMD.0000000000010904/rivista:Medicine (Baltimore. Online)/anno:2018/pagina_da:e10904/pagina_a:/intervallo_pagine:e10904/volume:97
Medicine
Introduction: Paraganglioma (PGL) is a rare neuroendocrine tumor. Currently, the malignancy is defined as the presence of metastatic spread at presentation or during follow-up. Several gene mutations are listed in the pathogenesis of PGL, among which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8296cfea1e8dacd6eb06cad4335ca4
https://publications.cnr.it/doc/399405
https://publications.cnr.it/doc/399405
Autor:
Barbara Bucci, Serena Pezzilli, Antonio Stigliano, Vincenzo Toscano, Federica Innocenti, Rita Canipari, Lidia Cerquetti
Publikováno v:
The Journal of endocrinology. 234(1)
Mitotane (MTT) is an adrenolytic drug used in advanced and adjuvant treatment of adrenocortical carcinoma, in Cushing’s disease and in ectopic syndrome. However, knowledge about its effects on the ovary is still scarce. The purpose of this study is
Publikováno v:
Recenti progressi in medicina. 107(11)
ACTH-independent adrenal Cushing's syndrome is the least common form of endogenous hypercortisolism. Recently, advances in genetics have allowed the description of several forms different to pathogenetic etiology, morphostructural characteristics and